02/27/2025
6:45 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:45 AM | Heron Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
12:51 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
4:40 PM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 4/A | |
02/04/2025
4:23 PM | Christian Waage (Reporting)
Heron Therapeutics (Issuer)
| Form 4/A | |
02/04/2025
4:27 PM | Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
| Form 4/A | |
02/04/2025
4:30 PM | Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
| Form 4/A | |
02/04/2025
4:34 PM | Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
| Form 4/A | |
02/04/2025
4:37 PM | Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
| Form 4/A | |
02/04/2025
11:43 AM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
11:44 AM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for HRTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Heron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/04/2025
11:44 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:58 AM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:48 AM | Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:41 AM | Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:32 AM | Christian Waage (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:33 AM | Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
8:17 AM | Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
8:32 AM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
8:15 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
8:06 AM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:05 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
4:15 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Heron Therapeutics (Subject)
| Form SC 13G | |
11/06/2024
1:08 PM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
11:41 AM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/04/2024
4:09 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Heron Therapeutics (Subject)
| Form SC 13G | |
10/21/2024
2:49 PM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
2:53 PM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:35 PM | Heron Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/22/2024
8:44 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
8:54 AM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
8:32 AM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:44 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
3:43 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
1:21 PM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:34 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
10:08 AM | Heron Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
05/29/2024
7:05 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:05 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Here’s how you could profit from Elon’s NVIDIA partnership (Ad) Elon Musk recently offered NVIDIA $1 billion...
To buy a cluster of their cutting-edge GB200 AI chips.
Why?
Because Elon is quietly building the most powerful AI supercomputer on the planet.
It's called "Project Colossus"... Don't know where to start investing in AI? Check out my latest investor briefing. |
05/07/2024
7:05 AM | Heron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
1:33 PM | Heron Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
1:36 PM | Heron Therapeutics (Filer)
| Form ARS | |
04/19/2024
4:48 PM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:02 PM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:21 PM | Heron Therapeutics (Filer)
| Form PRE 14A | |
04/19/2024
3:34 PM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
